Clinical experience with long-term studies of degenerative complications in man after pancreas transplantation

J. Traeger, J. M. Dubernard, L. D. Monti

Research output: Contribution to journalArticle

Abstract

The secondary complications of diabetes mellitus are the main cause of morbidity and mortality associated with the disease, and seem to be related to inadequate metabolic control achieved by traditional treatments. Pancreatic transplantation is a promising approach to normoglycaemia through a self-regulated source of insulin. There is experimental evidence that pancreas transplantation may prevent degenerative complications of diabetes and reverse microangiopathic renal lesions. Nevertheless, technical aspects of pancreatic transplantation remain to be solved on disposal of the exocrine secretions. Several methods have been proposed: pancreatic duct ligation, intestinal diversion, injection of the pancreatic duct with polymers, and urinary diversion. Intracanalicolar Neoprene (Dupont, Wilmington, DE) injection, which produces atrophy of the exocrine portion of the pancreas with preservation of the beta cells, is in our experience, a safe technique. Nevertheless many authors have reported fibrosis extending to the endocrine portion of the pancreatic graft, and this could cause loss of a pancreatic graft in the long term. The aim of this study was to investigate the long-term endocrine metabolic function and degenerative complications of patients allotransplanted with Neoprene-injected pancreas.

Original languageEnglish
Pages (from-to)1750-1751
Number of pages2
JournalTransplantation Proceedings
Volume18
Issue number6
Publication statusPublished - 1986

Fingerprint

Neoprene
Pancreas Transplantation
Pancreatic Ducts
Diabetes Complications
Transplantation
Transplants
Exocrine Pancreas
Urinary Diversion
Injections
Atrophy
Ligation
Pancreas
Polymers
Fibrosis
Insulin
Morbidity
Kidney
Mortality
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Clinical experience with long-term studies of degenerative complications in man after pancreas transplantation. / Traeger, J.; Dubernard, J. M.; Monti, L. D.

In: Transplantation Proceedings, Vol. 18, No. 6, 1986, p. 1750-1751.

Research output: Contribution to journalArticle

@article{6430d7cf667e47e097c25b2bdab5bd36,
title = "Clinical experience with long-term studies of degenerative complications in man after pancreas transplantation",
abstract = "The secondary complications of diabetes mellitus are the main cause of morbidity and mortality associated with the disease, and seem to be related to inadequate metabolic control achieved by traditional treatments. Pancreatic transplantation is a promising approach to normoglycaemia through a self-regulated source of insulin. There is experimental evidence that pancreas transplantation may prevent degenerative complications of diabetes and reverse microangiopathic renal lesions. Nevertheless, technical aspects of pancreatic transplantation remain to be solved on disposal of the exocrine secretions. Several methods have been proposed: pancreatic duct ligation, intestinal diversion, injection of the pancreatic duct with polymers, and urinary diversion. Intracanalicolar Neoprene (Dupont, Wilmington, DE) injection, which produces atrophy of the exocrine portion of the pancreas with preservation of the beta cells, is in our experience, a safe technique. Nevertheless many authors have reported fibrosis extending to the endocrine portion of the pancreatic graft, and this could cause loss of a pancreatic graft in the long term. The aim of this study was to investigate the long-term endocrine metabolic function and degenerative complications of patients allotransplanted with Neoprene-injected pancreas.",
author = "J. Traeger and Dubernard, {J. M.} and Monti, {L. D.}",
year = "1986",
language = "English",
volume = "18",
pages = "1750--1751",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Clinical experience with long-term studies of degenerative complications in man after pancreas transplantation

AU - Traeger, J.

AU - Dubernard, J. M.

AU - Monti, L. D.

PY - 1986

Y1 - 1986

N2 - The secondary complications of diabetes mellitus are the main cause of morbidity and mortality associated with the disease, and seem to be related to inadequate metabolic control achieved by traditional treatments. Pancreatic transplantation is a promising approach to normoglycaemia through a self-regulated source of insulin. There is experimental evidence that pancreas transplantation may prevent degenerative complications of diabetes and reverse microangiopathic renal lesions. Nevertheless, technical aspects of pancreatic transplantation remain to be solved on disposal of the exocrine secretions. Several methods have been proposed: pancreatic duct ligation, intestinal diversion, injection of the pancreatic duct with polymers, and urinary diversion. Intracanalicolar Neoprene (Dupont, Wilmington, DE) injection, which produces atrophy of the exocrine portion of the pancreas with preservation of the beta cells, is in our experience, a safe technique. Nevertheless many authors have reported fibrosis extending to the endocrine portion of the pancreatic graft, and this could cause loss of a pancreatic graft in the long term. The aim of this study was to investigate the long-term endocrine metabolic function and degenerative complications of patients allotransplanted with Neoprene-injected pancreas.

AB - The secondary complications of diabetes mellitus are the main cause of morbidity and mortality associated with the disease, and seem to be related to inadequate metabolic control achieved by traditional treatments. Pancreatic transplantation is a promising approach to normoglycaemia through a self-regulated source of insulin. There is experimental evidence that pancreas transplantation may prevent degenerative complications of diabetes and reverse microangiopathic renal lesions. Nevertheless, technical aspects of pancreatic transplantation remain to be solved on disposal of the exocrine secretions. Several methods have been proposed: pancreatic duct ligation, intestinal diversion, injection of the pancreatic duct with polymers, and urinary diversion. Intracanalicolar Neoprene (Dupont, Wilmington, DE) injection, which produces atrophy of the exocrine portion of the pancreas with preservation of the beta cells, is in our experience, a safe technique. Nevertheless many authors have reported fibrosis extending to the endocrine portion of the pancreatic graft, and this could cause loss of a pancreatic graft in the long term. The aim of this study was to investigate the long-term endocrine metabolic function and degenerative complications of patients allotransplanted with Neoprene-injected pancreas.

UR - http://www.scopus.com/inward/record.url?scp=0022902566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022902566&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0022902566

VL - 18

SP - 1750

EP - 1751

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 6

ER -